Ducking Under the Trend Lines, Shares Look for a Catalyst: Clovis Oncology, Inc. (NASDAQ:CLVS)

Clovis Oncology, Inc. (NASDAQ:CLVS) stock has been on a recent steady downtrend, causing some concern for shareholders.

In order to gauge which way a stock is trending, you must compare a stock’s share price to its moving average.  Uptrending stocks trade above their moving averages, while downtrending stocks trade below. 

It is important to consider the moving averages of a downtrending security.  We see here that Clovis Oncology, Inc. (NASDAQ:CLVS) is -11.12% away from the 20-Day Simple Moving Average.  Their 50-Day Simple Moving Average is a difference of -20.22% from current levels.  Further back, their 200-Day Simple Moving Average is -15.22% difference from today’s price.  Currently, the stock is -31.35% from its 50-Day High and 2.81% from the 50-day low. 

RSI and Recommendations

Clovis Oncology, Inc.’s RSI is 25.39.  Based on the stock’s volatility for the week, which is a statistical measure of the dispersion of returns for a given stock and represents average daily high/low percentage range of 3.99% and month of 4.49%.  Wall Street analysts have a consensus 2.00 recommendation on the stock.  

Historical Growth

Clovis Oncology, Inc. (NASDAQ:CLVS)’s performance this year to date is 32.76%.  The stock has performed -7.69% over the last seven days, -23.41% over the last thirty, and -16.52% over the last three months.  Over the last six months, Clovis Oncology, Inc.’s stock has been 14.15% and 71.47% for the year.

Leave a Comment